38
Participants
Start Date
June 20, 2025
Primary Completion Date
June 30, 2032
Study Completion Date
June 30, 2035
PHOX2B PC-CAR T Cells
The PHOX2B PC-CAR T cell investigational product is comprised of autologous human T cells that have been genetically modified to express a a PHOX2B-targeting chimeric antigen receptor (CAR) transgene.
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Philadelphia
OTHER
Alliance for Cancer Gene Therapy
OTHER
Children's Cancer Research Fund
OTHER
Stephan Grupp MD PhD
OTHER